Cav1.2 channelopathies causing autism: new hallmarks on Timothy syndrome by Marcantoni, Andrea et al.
14 December 2021
AperTO - Archivio Istituzionale Open Access dell'Università di Torino
Original Citation:





(Article begins on next page)
Anyone can freely access the full text of works made available as "Open Access". Works made available under a
Creative Commons license can be used according to the terms and conditions of said license. Use of all other works
requires consent of the right holder (author or publisher) if not exempted from copyright protection by the applicable law.
Availability:
This is the author's manuscript
This version is available http://hdl.handle.net/2318/1785552 since 2021-06-30T09:16:27Z
Query Details Back to Main Page
1.   Please check if the author names and affiliations are presented/captured correctly.
Addresses and names are ok
2.   Please check if the section headings are assigned to appropriate levels.
Section headings are ok. I only made some comments on the size of lettering.
Invited Review
Cav1.2 channelopathies causing autism:
new hallmarks on Timothy syndrome
Andrea Marcantoni, 





 Department of Drug Science, Laboratory of Cellular and Molecular
Neuroscience,  N.I.S. Centre,  Corso Raffaello 30,  10125  Torino,  Italy
 Department of Biophysics, Faculty of Medicine,  Akdeniz University,
Antalya,  Turkey
Received: 11 June 2020 / Accepted: 26 June 2020
Abstract
Cav1.2 L-type calcium channels play key roles in long-term synaptic








novo mutations in the gene encoding Cav1.2 (CACNA1C) causes two forms of
Timothy syndrome (TS1, TS2), characterized by a multisystem disorder
inclusive of cardiac arrhythmias, long QT, autism, and adrenal gland
dysfunction. In both TS1 and TS2, the missense mutation G406R is on the
alternatively spliced exon 8 and 8A coding for the IS6-helix of Cav1.2 and is
responsible for the penetrant form of autism in most TS individuals. The
mutation causes specific gain-of-function changes to Cav1.2 channel gating: a
“leftward shift” of voltage-dependent activation, reduced voltage-dependent
inactivation, and a “leftward shift” of steady-state inactivation. How this
occurs and how Cav1.2 gating changes alter neuronal firing and synaptic
plasticity is still largely unexplained. Trying to better understanding the
molecular basis of Cav1.2 gating dysfunctions leading to autism, here, we will
present and discuss the properties of recently reported typical and atypical TS
phenotypes and the effective gating changes exhibited by missense mutations
associated with long QTs without extracardiac symptoms, unrelated to TS. We
will also discuss new emerging views achieved from using iPSCs-derived
neurons and the newly available autistic TS2-neo mouse model, both
appearing promising for understanding neuronal mistuning in autistic TS
patients. We will also analyze and describe recent proposals of molecular
pathways that might explain mistuned Ca -mediated and Ca -independent
excitation–transcription signals to the nucleus. Briefly, we will also discuss
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Cav1.2 (encoded by the gene CACNA1C) is an L-type calcium channel with
broad tissue expression profile, including cardiac and neuronal tissues, smooth
muscle, pituitary, and adrenal glands [21, 23, 30, 103]. Cav1.2 channels open
upon cell depolarization to enable Ca  influx and initiate intracellular Ca -
mediated signaling [44, 47]. Alterations in intracellular Ca  signaling have been
widely associated with neuropsychiatric diseases [9, 13, 48]. This is confirmed
by genome-wide association studies (GWAS) of patients with bipolar disorder,
schizophrenia, and autism spectrum disorders (ASD) in which have been
identified gain- (GOF) and loss-of-function (LOF) mutations in CACNA1C [34,
40, 62, 78]. Despite the clear indications of genetic changes in Cav1.2 function,
little is known on how Cav1.2 affects the key cellular and molecular processes
that lead to neurodevelopmental psychiatric disorders.
Timothy syndrome (TS), also known as long QT syndrome 8 (LQTS8), is a rare
multiorgan CACNA1C channelopathy characterized by cardiac arrhythmias, long
QTs, syndactyly, dysmorphic facial features, intermittent hypoglycemia, immune
deficiencies, and neurodevelopmental disorder [86, 87]. TS is associated with a
de novo single point GOF mutation in CACNA1C, the gene encoding the α1
pore-forming subunit of Cav1.2 channels and occurs in two major forms (TS1
and TS2), depending on whether the point mutation appears on exon 8A [87] or
exon 8 [86]. The two exons code for the IS6 helix of the Cav1.2 channel
controlling the voltage dependence of channel activation and inactivation. In the
TS type 1 (TS1), the mutation occurs at Gly406 (G406R) in close proximity to
the intracellular I-II loop of exon 8A. In TS type 2 (TS2), the mutation occurs
either at Gly406 (G406R) or at Gly402 (G402S) within exon 8, which is highly
expressed in the brain and heart (80%) and to a lesser extent in the adrenal
glands [86]. Both gain-of-function mutations affect Cav1.2 gating by drastically
reducing channel inactivation and increasing Ca  influx during cell
depolarization. This causes prolongation of cardiac action potential (AP), long
QT, and ventricular arrhythmias that are the most severe pathological conditions
of TS patients [12].
TS1 and TS2 patients present autistic forms of behavior, which are more evident
in TS2 patients since exon 8 is more expressed in the brain than exon 8A.
Curiously, TS2 patients carrying the G402S mutation exhibit severe
cardiopathies but are neurologically intact while patients with G406R mutation
display both cardiopathies and autism spectrum disorders (ASD) [35, 45, 86].
Recent findings suggest that the ability of the G406R vs. G402S mutation in
inducing neurological abnormalities [52, 84] may be linked to a gating change
associated with Cav1.2 channel activation. Indeed, G406R and G402S mutations




Mutant G406R shifts the voltage dependence of activation toward more negative
potentials, whereas G402S shifts the activation in the opposite direction [28, 76].
A marked negative shift of voltage-dependent activation favors L-type channel
openings near resting potentials, thus causing basal increases of inward Ca
fluxes that could boost Ca -mediated neuronal gene expression. Well-resolved
negative shifts of the voltage dependence of Cav channels are also characteristic
of point mutations A749G, V401L, and S652L of the L-type Cav1.3 α1-subunit,
coded by the CACNA1D gene, identified in individuals with ASD or global
developmental delay [46, 72, 73]. Of relevance, in the Cav1.3 GOF mutations,
channel inactivation is delayed only in the V401L mutation, while inactivation is
accelerated in A749G and S652L, suggesting that “slowing” or “acceleration” of
Cav1 channels inactivation is most likely not relevant for altering
neurodevelopmental disorders leading to ASD.
TS is one of the most penetrant monogenic forms of autism, with a percentage as
high as 60–80% [17, 86, 87]. As for other Cav channelopathies, TS is widely
studied using either heterologous expression of Cav1.2 mutants in clonal cell
lines [8, 14, 28, 31, 87, 98, 101] or neurons induced from pluripotent stem cells
(iPSCs) of individuals with TS [51, 69–71, 102]. The first approach has been
fundamental to identify the hallmarks of Cav1.2 activation and inactivation
gating changes induced by the TS mutations, to test blockers of the TS-mutated
Cav1.2 channels and design in silico models of TS-altered AP waveforms. The
second approach allowed recognizing defects in Ca  signaling in iPSC-induced
neurons of TS patients that induce major alterations in the regulation of gene
transcription downstream of activity-dependent Ca  entry via Cav1.2 channels
[51, 69, 71].
An alternative approach to study TS-induced cellular and molecular changes
associated with ASD is the use of the recently available knock-in TS2-neo
(G406R) mouse model. The mouse exhibits social impairment, communication
deficits, and repetitive behaviors as well as poor sensorimotor learning
reminiscent of autism [4, 7, 10, 77]. TS2-neo mice have normal weight [49] and
largely normal brain size [4], but display structural anomalies in the medial
geniculate nucleus (MGN) [77], altered brain activities that are common across
several ASD mouse models [29], and enhanced oligodendrocyte progenitor cells
development and oligodendrocyte myelination [24]. The TS2-neo mouse has
been recently used to study the cellular and molecular changes of adrenal
chromaffin cells (CCs) [20] that could explain the severe bilateral adrenal gland
dystrophy reported after post-mortem autopsy of a 2-month-old TS patient [50].
Using adrenal CCs of heterozygous TS2-neo mice, it could be shown that the
G406R mutation prolongs the inactivation and shifts leftward the activation and





resting Ca  influx (“window” Ca  current) [20]. The increased basal Ca
causes marked reduction of Nav channel density, switches normal AP firing from
tonic to bursts, reduces mitochondrial metabolism, induces cell swelling, and
decreases catecholamine release, providing evidence that CC malfunction
derives from the altered Cav1.2 channel gating.
Here, we will provide a detailed review of the classical and new hallmarks of TS
that could cause altered neuronal firing, neurodevelopmental disorders, and
ASD. We will discuss new forms of typical and atypical TS recently associated
with GOF mutations of CACN1C and the rationale of newly proposed Cav1.2-
mediated excitation–transcription (E-T) coupling models that triggers gene
activation via a cascade of protein–protein interactions [51, 52, 83, 84]. We will
also discuss new hallmarks of TS pathophysiology emerging from studies with
the TS2-neo mouse model and iPSC-induced neurons and highlight some new
pharmacological evidence for the treatment of TS, promoting the management of
this rare disease.
The Cav 1.2 Cav1.2 1.2 of the same size of C  channel
structure
Cav1.2 channels are hetero-oligomeric complexes that include the pore-forming
transmembrane α1-subunit, the intracellular β-subunit, and the extracellular α2δ-
subunit. The α1-subunit is composed of more than 1800 amino acids and is
responsible for most of the pharmacological and gating properties of the
channel. The other components serve as auxiliary subunits and modulate the
function of the channel. The structural topology of the α1-subunits is highly
conserved among the members of the Cav1 L-type channel family and is
composed of the cytoplasmic N- and C-terminal domains and four homologous
repeats (I-IV) with six transmembrane segments each (S1–S6 α-helices) (Fig. 1).
Fig. 1
Predicted topology of the pore-forming Cav1.2 α1-subunit showing the location of
TS1 and TS2 mutations and interactions with β subunit and Ca  CaM. The α1
subunit consists of four homologous repeats (I–IV), each comprising six
transmembrane helices (S1–S6). From each repeat, S1–S4 form the voltage
sensors. The S4 helices (orange) contain positive gating charges. S5–S6 with their
connecting P loop form the ion conducting pore. The S4–S5 loop links the voltage
sensor movements to the pore opening. The SH3-GK domains and the positions of
the β subunit/AID complex at the I–II linker and Ca -CaM in proximity of PreIQ




The voltage sensor module Segments S1–S4 of each repeat form the voltage-
sensing domain (VSD) and segments S5–S6 with the connecting P loop form the
pore domain and selectivity filter [23, 44]. The S4 α-helices contain four to five
positively charged amino acid residues (arginines or lysines) that serve as the
actual voltage sensors of the voltage-dependent gating mechanism. The S1–S3
helices of the VSD contain several negatively charged amino acids and polar
residues that stabilize the positively charges of S4 [93]. Upon depolarization, the
S4 segments move outward, and their movement is transmitted through the S4–
S5 linkers to the cytoplasmic ends of S5 and S6 helices, causing a
conformational change that opens the channel pore [92].
The voltage-dependent and Ca -dependent inactivation The inner part
of the S6 segments that lines the inner vestibule of the pore form part of the
docking site for the fast voltage-dependent inactivation (VDI) gate [85, 91]. In
response to membrane depolarization, the S6 segments undergoes a slight
conformational change that unmasks the docking sites at the cytoplasmic ends of
the segments to which the intracellular I–II linker gating particle binds and block
Ca  permeation [89]. The I–II linker acts as a “hinged lid” that physically
occludes the pore by docking to the cytoplasmic ends of the S6 segments [88].
Other intracellular regions, such as the N- and C-termini, as well as the III–IV
linker both directly or allosterically interact with the inactivation machinery and
play a critical role in the regulation of VDI [91].
2+
2+
The Ca -dependent inactivation (CDI) of Cav1 channels serves as the
autoinhibitory control for Cav1 channels to control the levels of intracellular
calcium and occurs in addition to VDI during depolarization. Calmodulin (CaM)
can be considered an additional channel subunit and has a prominent role in the
intrinsic mechanisms of CDI. Upon Ca  binding, CaM undergoes a
conformational change that interacts with additional C-terminal effector sites
promoting channel inactivation. The long cytoplasmic C-terminal region of the
α1-subunits contains the effector domains for Ca –CaM modulation (Fig. 1).
Specifically, Ca –CaM binds to an isoleucine-glutamine “IQ” domain located in
the C-terminal cytoplasmic tail ~ 150 amino acids downstream the last
transmembrane segment, IVS6 (for details see [61]). Besides being the locus of
CDI, the C-terminus is the target of numerous protein–protein interaction and
serves as an important modulatory domain for Cav1.2 channels.
The AID/β-subunit complex Cav1.2 channels strictly require an auxiliary β-
subunit for trafficking the channels to the plasma membrane, fine-tuning channel
gating, and regulating channel modulation by other proteins and signaling
molecules [18]. All Cav1.2 β-subunits (β1-β4) bind with high affinity (2 to
54 nM) to the 18 amino acid α1-subunit interaction domain (AID), which is
located in the first half of the intracellular I–II linker of Cav1.2 α1-subunits [74]
(Fig. 1). β-subunits are proteins of ~ 60 kDa, consisting of a conserved core
region flanked by non-conserved N- and C-termini [26, 43, 66]. The core region
of the β-subunits is composed of two highly conserved regions homologous to
the Src homology 3 (SH3) and guanylate kinase (GK) domains, connected by a
weakly conserved HOOK domain that recapitulate many key functions of the
subunits [19]. Crystal structure studies show that the AID binds to a hydrophobic
groove in the GK domain termed the AID-binding pocket (ABP) [61] (Fig. 1).
The extensive and predominantly hydrophobic interactions between AID and
ABP account for the high affinity of the AID/β-subunit binding. Of relevance for
the pathophysiology of TS is the possible role of β-subunits as transcriptional
regulators that has been demonstrated for both short splice variants and full-
length β-subunits [18, 90]. There is now increasing evidence that β-subunits can
translocate to the nucleus under specific stimuli and induce transcriptional
regulation [32, 83]. The AID I-II linker domain is closely located to the G406R
mutation in IS6, and it is thus likely that conformational changes of TS mutant
Cav1.2 channels affect the β-subunit binding to induce ET signals and gene
transcription in neurons [32, 84].
Cav 1.2 Cav1.2 1.2 of the same size as C  gain-of-function





Given the importance of Cav1.2 for many body functions, it was somewhat
surprising that many years after the L-type channel genes were identified [22];
no mutations were discovered in Cav1.2 channels. The absence of Cav1.2
channelopathies was even more surprising since deletion of the pore-forming
Cav1.2 channel gene in mice results in embryonic lethality ~ 2 weeks post
coitum [80]. This suggested that mutations causing critical changes in Cav1.2
channels are very likely embryonically lethal, and mutations associated with
weak effects on Cav1.2 channel gating can be well tolerated, and individuals
may show no obvious phenotypes [53].
The typical TS phenotypes In 2004, TS was reported for the first time as a
novel disorder associated to an L-type channel mutation identified as a sporadic
heterozygous single point mutation in the Cav1.2-encoding gene CACNA1C
[87]. TS individuals were characterized as affected by a multiorgan dysfunction
with lethal arrhythmias (long QT), syndactyly, congenital heart disease, immune
deficiency, craniofacial abnormalities, hypoglycemia, cognitive abnormalities,
and autism. A single missense mutation in position G406R in the alternatively
spliced exon 8A was identified as the cause of TS1. A year later, the same group
reported an analogous de novo G406R mutation and a second G402S missense
mutation in exon 8 causing severe long QT syndromes, syndactyly, and other TS
phenotypes [86], identified as TS2 (Fig. 1). Mutation G406R is in both exon 8A
and exon 8 while mutation G402S is only on exon 8. Both exon 8 and 8A code
for the IS6 segments of CACNA1C. The two mutations occur near the end of the
IS6 segment upstream of the I–II linker responsible for channel inactivation.
Mutations of G406 into an arginine and G402 in to a serine attenuate the rigid α-
helix and thus weaken Cav1.2 channel inactivation. Both mutations of
alternatively spliced exon 8A alter also Cav1.2 channel activation that are
controlled by the end groups of the four S6 α-helices lining the pore (see above).
Specifically, the mutations cause a GOF of Cav1.2 activity by slowing the time
course of channel inactivation (less complete fast inactivation), thus prolonging
Ca  influx during steady depolarization. This accounts for the prolonged
cardiac AP duration and long QT syndrome, which is more pronounced in TS2
patients since exon 8 is more highly expressed in cardiac than in smooth muscle
tissue (80% vs. 20%) [86, 87]. The TS mutations account also for some of the
extracardiac phenotypes observed in TS patients. For instance, hyperinsulinemia
and corresponding intermittent hypoglycemia and craniofacial abnormalities
reported in most TS patients. Cav1.2 calcium channels are the major contributors
of Ca -dependent insulin secretion from pancreatic β cells [100] and drive




Data of many groups indicate that G406R and G402S mutations cause a
prominent loss of the VDI rather than an attenuation of the CDI. Indeed, the
reduced fast inactivation is clearly visible when recording Ba  currents through
TS1 or TS2 mutant Cav1.2 channels, either heterologously expressed in HEK
293 cells [8, 76, 86, 87, 101] or isolated from primary cultures of TS2-mutated
excitable cells [20]. There is, however, evidence for a reduced CDI in adult
guinea pig myocytes transfected with G406R and G402S mutated channels that
accounts for the different threshold behavior in the induction of arrhythmias
associated with the two TS mutations [28]. A reduced CDI is also evident in the
corresponding G406R and G406S Cav1.2-mutated channels of rabbit,
heterologously expressed in Xenopus oocytes [76]. In silico modeling predicts
that, due to the weakened VDI (or CDI), TS-mutated channels fail to close
during the plateau phase of cardiac AP, thus increasing the inward Ca  current
that markedly delay AP repolarization.
The critical Cav 1.2 Cav1.2  gating changes leading to autism While
decreased VDI and CDI account for several of the phenotypic properties of TS,
they hardly account for the autistic forms present in over three quarters of TS
individuals. Several observations support this view. First, TS2 patients bearing
the G402S mutation are neurologically intact [35, 45] despite causing an
analogous reduction of VDI. Second, missense mutations of Cav1.3 channels in
position V401L, S652L, and A749G associated with forms of autism or mental
retardation cause either a decreased (V401L) or an increased VDI (S652L,
A749G) [46, 72, 73]. Third, dendritic retraction occurring after expression of the
G406R mutant channel in cultured neurons develop through a Ca -independent
signaling process that is also activated in the presence of non-conductive G406R
TS mutant channels [51]. All these results indicate that neuronal dysfunctions
can proceed regardless of reduced VDI.
A gating parameter that appears very critical for the development of autism is
the lowered threshold of Cav1.2 channel activation that is associated with the
“negative shift” of voltage-dependent activation induced by the G406R TS
mutation [20, 28, 52]. Substitution of Gly406 with a hydrophilic residue (Arg,
Lys, Asp, Glu) invariably promote the activated state of Cav1.2 by shifting the
voltage dependence of activation toward negative potentials. Maximal shifts
occur for Asp (− 7.3 mV) followed by Arg (− 6.2 mV) substitution [76]. Charged
residues replacing the stabilizing glycine at the 406 position of the IS6 segment
are expected to increase the flexibility of the α-helix that facilitates channel
activation. At the same time, the G406R mutation acts on the I–II linker to
weaken its folding back over the intracellular mouth of the pore, slowing the




substitution of G402 with serine causes a positive shift of voltage-dependent
activation (+ 3.2 mV) [76]. The shift is confirmed by Dick et al. [28] in G402S-
transfected adult myocytes from guinea pig (~ + 13 mV). The negative voltage
shift of Cav1.2 channel activation is thus very likely a key mechanism that may
contribute to neuronal mistuning in developing neurons.
A second important parameter of great significance in L-type channel
dysfunction associated with ASD and other forms of intellectual disabilities is
the percentage of Cav1 channels that are open at resting potentials where
neurons and excitable cells spend most of their time of activity (% of channels
availability). This determines the amplitude of the so-called “window Ca
current” that sets the steady influx of Ca  at rest but also establishes a
significant open-closed channel kinetics that sustains Cav1.2 channel
conformation changes at rest [20]. This current for the G406R TS2 mutant is
significantly increased and shifted to more negative voltages than for WT
channels ( [20] see below). Similar shifts are reported for the atypical TS
mutation I1166T [16] and for the A749G, V401L, and S652L Cav1.3 mutations
where steady-state inactivation (SSI(V); % of channels availability) and channel
conductance (g (V)) are systematically measured [46, 72, 73]. Notice that
mutations I1166T, A749G, and S652 are L-type channel mutations associated
with identified human phenotypes with autism or intellectual disabilities in
which the rate of inactivation is increased rather than decreased as in TS1 and
TS2 mutants (see below).
Atypical Cav 1.2 Cav1.2  gain-of-function mutations
causing TS
Besides the two classical CACNA1C mutations causing TS (G406R and G402S),
there are three recently reported cases of atypical Cav1.2 GOF mutations
associated with long QT and extracardiac phenotypes occurring in exons other
than exons 8A/8 [16, 39, 68, 98] (Fig. 2). The first case is a de novo A1473G
mutation occurring at the end of the Cav1.2 IVS6 segment (in exon 38)
identified in a child diagnosed with markedly prolonged QT interval,
dysmorphic facial features, syndactyly, joint contractures, and later profound
developmental delay [39]. Functional studies of this mutation in heterologous
expression systems were not reported but it is likely that the mutation is a GOF
similar to the TS1 and TS2 mutations. Mutation A1473G is upstream the C-
terminus and can possibly interact with the I–II linker, altering the flexibility of





Scheme of the position of missense mutations within the Cav1.2 α1 subunit
causing TS with autism, TS without autism, or simply LQTS type 8 without TS.
The components of the four homologous repeats (I–IV) of the Ca1.2 α1 subunit are
indicated as in Fig. 1. Circles indicate the position of missense mutations either
causing TS associated to ASD (filled red), causing TS without ASD (filled green),
or simply causing LQTS type 8 without TS syndrome (empty red). Mutations
P381S, M456I, and G1783C are added as reported in ref. (36)
The second case is a de novo I1166T mutation within the III–IV linker (in exon
28) discovered through a whole exome sequencing (WES) in a subject with long
QT, a patent ductus arteriosus, facial dysmorphisms, various digit abnormalities,
intellectual impairment, and tooth decay [16]. A similar case with the same
mutation, but without syndactyly, was reported also for a 1-year-old female
identified in a study of 540 LQTS probands [98]. Mutant channels co-expressed
in HEK 293 cells exhibit the typical negative voltage shift of channel activation
and nearly no effect on SSI suggesting an increased window Ca  current near
resting potentials. Inactivation was in one case unchanged [16], while in the
other case was partially reduced [98] as expected from a Cav1.2 mutation
causing TS. Possible reasons for this discrepancy could be their dependence on
different β2- and α2δ-subunits used during the co-expression procedure [98].
Taken together, it is evident that the I1166T mutation causes a GOF phenotype
resembling classical TS1 and TS2.
2+
The third case is a de novo S436F mutation located in the intracellular S4–S5
linker of domain II, identified in a TS proband without syndactyly but with
severe cardiac phenotype [68]. The patient was a 14-year-old boy with
prolonged QT interval, dysmorphic facial features (round face, flat nose, and
low-set ear), and intellectual disability that was diagnosed as ASD at age 12.
Functional studies of the mutant channel using HEK cells exhibited inward Ca
currents during step depolarizations whose voltage-dependent activation was
markedly leftward shifted [68]. Peak current amplitude was significantly reduced
and fast inactivation was markedly attenuated. Given that the inactivation gating
changes persisted when Ca  was replaced with Ba , it was concluded that the
S436F mutant altered preferentially the VDI of Cav1.2 channels. In conclusion,
it is evident from the positions of the three mutations causing atypical TS that
the regions of CACNA1C mainly involved in the autistic forms of TS are amino
acid located at the far end of three S6 segments and the S4-S5 linker that line the
inner vestibule of the pore [92]. These domains of the α1-subunit control Cav1.2
channel activation and inactivation; thus, critical mutations in these regions shift
toward more negative potentials the activation of Cav1.2 channels and prolong
the coupled VDI of the channel [89].
CACNA 1 CACNA1C 1 is not small C channelopathies
causing long QT but not TS: indications for specific
Cav1.2 Cav1.2 1.2 same size as C domains inducing
autism
Surprisingly, GOF mutations in Cav1.2 channels were for a long time
exclusively linked to TS [1, 4, 13, 33, 67, 75, 86, 87]. GOF mutations in
CACNA1C started to be identified following WES in cohorts of familial LQTS
without extracardiac symptoms [15, 36]. P857R was the first gain-of-function
mutation discovered in the conserved PEST domain (the Pro, Glu, Ser, Thr
motif) of the Cav1.2 II–III linker (Fig. 2). Compared with the presently known
TS mutations, the new GOF mutation was located in an unusual domain: the II-
III linker. When functionally expressed in HEK293 cells, it was evident that the
P857R-induced GOF effects derived from an increased surface expression and
not from an altered activation and inactivation gating of the mutant channel. The
P857R appeared as an atypical GOF mutation unrelated to TS. A year later,
Fukuyama et al. [36] described two other Cav1.2 gain-of-function mutations
associated with LQT8: A582D and R858H. When expressed in Chinese hamster
ovary (CHO) cells, the A582D mutant caused a significant slowing of fast
inactivation, while the R858H mutant increased the peak current density by ~ 
50%. Unfortunately, the extent of SSI that is affected in TS mutants was not
2+
2+ 2+
analyzed for the two mutations so that their effects could not be compared with
those causing TS (Fig. 2).
In a more recent study, four GOF mutations not causing TS, but able to induce
solitary long QT syndromes, were described in CACNA1C [98]. When expressed
in Xenopus oocytes, two mutations (A28T and I1166V) caused increased Ba
current amplitudes, very little changes to the voltage dependence of channel
activation but substantially reduced VDI for A28T. SSI was either weakly
(I1166V) or markedly (A28T) positively shifted with little changes to the
voltage dependence of activation with respect to WT channels; it was concluded
that the two GOF mutations were able to cause a prolongation of in silico
simulated ventricular APs, though their phenotypes were significantly different
from those causing TS. Significantly different were the effects of the two other
mutations (I1475M and E1496K) which produced gating effects impressively
similar to TS: a leftward shift of the voltage dependence of activation, reduced
VDI (particularly for the E1496K mutant), and incomplete SSI at very positive
potentials (+ 40 mV), strongly resembling those characteristics of the TS1 and
TS2 G406R mutation causing autism. These data are of key importance. They
suggest that activation-inactivation gating changes causing GOF in mutated
Cav1.2 channels are not the only parameters that uniquely set the conditions for
the development of ASD. Development of ASD requires GOF mutations located
at specific sites, i.e., close to one of the four S6 segments, as in the case of the
G406R mutation located in IS6, I1166 in IIIS6 and A1473G in IVS6 (Fig. 2).
Cav1.2 Cav1.2  LOF mutations L-type Ca  channel genes do not undergo
only GOF mutations but may as well exhibit LOF mutations with associated
short QT intervals that are responsible for the Brugada syndrome (BrS). In a
screening study of 82 BrS patients, several mutations in CACNA1C and
CACNB2 have been identified [2]. Two of the BrS probands had substitutions in
CACNA1C leading to A39V or G490R mutations in Cav1.2 and one patient with
the mutation S481L in Cavβ2b. All three mutations produced dramatic LOF of
Ca  currents that could result from changes in channel gating, permeation, or
trafficking. For a more detailed description on the CACNA1C mutations causing
BrS, see reference (12).
New emerging views from the TS 2 TS2 2 is not small -
neo mouse model
About 10 years ago, Glenna Bett and Randal Rasmusson at Buffalo University
generated heterozygous mice with the G406R mutation on exon 8 and an
inverted neomycin cassette in exon 8A (TS2-neo) to allow the animal to survive




vocalization, and restricted and repetitive/perseverative behavior that are key
features reminiscent of ASD [4] (see also [49, 77] for validation). The TS2-neo
mouse is autistic without any cardiac abnormalities and is thus suitable to
investigate mechanisms underlying ASD in which the molecular and cellular
functions are affected by dysfunctional Cav1.2 channel gating [11].
Several recent papers have used the TS2-neo mouse to investigate the role of
Cav1.2 calcium signaling in atypical brain development at molecular, cellular,
and brain region levels as it is, without removing the protective neo-cassette.
The TS2-neo mouse shows enhanced serotonin levels and axon innervation of
the dorsal striatum suggesting that the ascending serotonin system is altered by
Cav1.2 channels, as it occurs in several other ASD mouse models [29].
Stercobilin is dramatically reduced in fecal samples of TS2-neo mice [81], in
line with observations of diverse microbiome metabolism in humans with ASD
and with the idea that stercobilin may be used as a biomarker for ASD [25].
Impaired Cav1.2 channel gating was also observed to significantly enhance
performance on an auditory processing task in TS2-neo mice [77], in good
agreement with the enhanced low level perceptual discrimination for auditory
stimuli observed in individuals with ASD [67]. TS2-neo mice have been used
also to study how G406R-mutated channels alter the activity-dependent dendrite
retraction induced by long-lasting KCl depolarizations in mouse cortical neurons
[51]. Dendrite retraction appears independent of Ca  permeation through the
mutant channel and is activated by the RhoA signaling cascade through the
down regulation of the small G protein Gem bound to β-subunits. This study
represents the first evidence that TS signaling may proceed independently of
Ca  influx. In other words, simply through conformational changes of mutated
Cav1.2 channels that trigger a cascade of protein–protein interactions (see [83].
The TS2 mouse model has been used also to study how oligodendrocyte
progenitor cells (OPCs) isolated from the cortex of TS2-neo mice trigger process
formation and promote oligodendrocyte–neuron interaction via the activation of
CaMKII [24]. OPC development and oligodendrocyte myelination is enhanced
in the brain of TS2-neo mice, suggesting that this mouse model is a useful tool
to explore the role of Cav1.2 channels in axon myelination.
Increased window Ca  currents in chromaffin cells of TS2 TS2 2 of the
same size of TS -neo mice The TS2-neo mouse has also been used recently to
investigate how the Cav1.2 G406R mutation on exon 8 alters the excitability and
secretory activity of adrenal chromaffin cells [20]. Mouse chromaffin cells
(MCCs) express high densities of Cav1.2 and Cav1.3 L-type channels and are
considered an excellent “neuron-like” cell model to study Cav channel function
under a variety of physiological stimulations [21, 54]. The study is also of




mortem autopsy revealed bilateral adrenal gland dystrophy due to a marked
shrinkage and severe fibrosis of the medulla, most likely associated with an
increased basal Ca  influx associated with the Cav1.2 G406R mutation [50].
Besides furnishing a valid explanation of the clinical case, our work [20] also
offers a realistic view of how much the TS mutation alters native Cav1.2 channel
currents, which normally represent a variable fraction (20 to 50%) of the total
Ca  currents driving neuronal activity. Pharmacologically isolated L-type
currents in TS2-neo MCCs exhibit the typical voltage dependence and time
course associated with the Cav1.2 TS-mutated channel reconstituted in
heterologous expression systems [8, 28, 87, 101], i.e., slower inactivation,
leftward shifted voltage-dependent activation, and steady-state inactivation (SSI)
(Fig. 3). Compared with the gating changes observed in heterologous expression
systems, the negative voltage shift of Cav1 channel activation and the slowing of
the voltage-dependent inactivation (VDI) were quite attenuated (Fig. 3b, c). This
is because Cav1.2 channels contribute only to 50% of the total L-type currents
[54, 60, 96], and exon 8 and exon 8A are equally expressed in MCCs due to the
protective effect of the inverted neo-cassette on exon 8A (see Fig. 2 in [20]).
Fig. 3
Voltage dependence of activation and steady-state inactivation (SSI) of L-type
currents are “left shifted,” and inactivation is slowed-down in TS2-neo-mutated
adrenal MCCs. a Two sets of pharmacologically isolated L-type Ca  currents
evoked by depolarizing pulses of 20 ms from − 40 to + 10 mV in step of 10 mV
from a WT and TS2-neo MCC in 2 mM Ca  (modified from ref. (20)). b
Normalized L-type Ca  channel conductance, g (V), for WT (black line) and
TS2-neo MCCs (red line) calculated from g (V) = I /(V–E ) with E  = + 
60 mV. It is evident the negative shift of g (V) (for details see fig. 4 in ref. (20)).
c Mean normalized L-type Ca  currents evoked by 1 s depolarizing pulses to + 
10 mV (left) for WT and TS2-neo MCCs. In the two mean traces are evident the
fast (CDI) and slowly inactivating (VDI) components of L-type Ca  currents
(modified from ref. (20)). d SSI(V) curves for WT (black squares) and TS2-neo
(red circles) MCCs. The two continuous curves are the results of a curve fit with











Of great interest here is the negative shift of the voltage-dependent activation
and SSI of TS2-mutated L-type currents (Fig. 3b, d) that gave rise to a markedly
increased “window Ca  current” that could steadily drive Ca  inside the cell
near resting potential. As shown in Fig. 4, the “window Ca  current” for WT-
and TS2-mutated channels is calculated by multiplying the SSI(V) (Fig. 3d) with
g (V) (Fig. 3b) to determine the probability of channel opening (p (V)). This
latter, multiplied by the driving force (V-E ), gives the window Ca  current
(I ). For the G406R TS2 mutant, this current is significantly larger and shifted to
more negative voltages than for WT channels (shaded area at the bottom of Fig.
4). Notice that L-type channels (particularly Cav1.3) open at relatively low
voltages in 2 mM Ca  in MCCs [57, 58], activate SK and BK potassium
channels [94, 96], and contribute significantly to sustain spontaneous and
evoked AP firing in cultured MCCs [56, 60]. Thus, a small continuous increase
(over days) of the resting pacemaking current induced by the mistuned Cav1.2
channel gating triggers a number of Ca -dependent pathways that affect cell
morphology and function [97]. As reported in our work, TS2-neo MCCs









justified a visually evident cell swelling (~ 24% of cell surface increase) and a
markedly reduced mitochondrial metabolism. In addition, Nav channels density
is drastically decreased, CCs undergo abnormal AP burst firing, and
catecholamine release is markedly attenuated. This latter is most likely due to
the cell swelling and modifications of the many structural elements that form the
complex secretory apparatus regulating the priming, docking, and fusion of
secretory granules [27]. Thus, taken all together, the TS2 mutation causes
marked impairment of adrenal chromaffin cells excitability and exocytosis.
Notice that a decreased density of Nav channels together with an increased
inward Ca  influx boost MCCs to fire in burst and generate further Ca  entry
[21, 41, 95], thus sustaining high levels of intracellular Ca .
Fig. 4
The “window Ca  current” is markedly increased in TS2-neo-mutated MCCs. L-
type current inactivation window Ca  current (I ) calculated from SSI(V) and
g (V) of Fig. 3. I  is obtained by multiplying the probability of channel opening
p (V) by the driving force (V–E ) with E  = + 60 mV (continuous curves in
bottom panel). The two p (V) curves are obtained by multiplying SSI(V) by
g (V) (dotted curves in top panel). Notice the increased amplitude of I  between










At present, there are no detailed finding characterizations for the excitability
properties of in vitro cortical and hippocampal neurons induced by the TS2
mutation on endogenous Cav1.2 channels. Preliminary data from our group
suggest that the same gating changes observed in the endogenous L-type
channels of MCCs are evident in primary cultures of hippocampal neurons of
mouse embryos [37, 38, 59, 79]. Figure 5a shows two examples of Ca  currents
at + 10 mV in 2 mM Ca  recorded from WT and TS2-neo hippocampal neurons
during early days in culture (3–7 days in vitro, DIV), in control (black trace),
and during application of 3 μM nifedipine to fully block L-type channels (blue
traces). The difference of the two currents (red traces), which represents the L-
type current component, shows that neuronal TS2-neo mutated L-type currents
are more slowly inactivating than WT currents (Fig. 5b). This is confirmed by
2+
2+
comparing the time course of 1 s averaged L-type currents from n = 6 WT and
n = 6 TS2-neo mutated hippocampal neurons (Fig. 5c).
Fig. 5
L-type current inactivation is slower and less complete in TS2-mutated 3–7 DIV
cultured hippocampal neurons. Hippocampal neurons were obtained from 18 days
mouse embryos and grown in culture according to ref. (38). Recordings of Ca
currents were limited to cultured neurons of 3–7 DIV for two reasons: (1) they
display short dendrites and recording is under the best conditions of voltage-clamp
control, and (2) the effects are studied at the early days in culture where most of
the cell reprogramming process takes place. a Ca  currents at + 10 mV from V  = 
− 80 mV recorded in the whole-cell mode under control conditions in 2 mM Ca
(black traces) and during addition of 10 μM nifedipine (blue traces) to block L-
type channels. The difference between the two traces (red traces) represents the
time course of L-type current. The external solution contained (in mM) 2 CaCl ,
150 NaCl, 1 MgCl , 10 glucose, and 10 HEPES (pH 7.4). Tetrodotoxin (0.3 μM)
was added to block Nav channels. The internal solution contained (in mM) 90
CsCl, 20 TEACl, 10 EGTA, 10 glucose, 1 MgCl , 4 ATP, 0.5 GTP, and 15
phosphocreatine (pH 7.4) (see ref. (5, 6)). b Overlapped L-type currents at + 
10 mV obtained from panel a. Notice the slower inactivating L-type current of
TS2-neo mutated neuron. c Average time course of normalized L-type currents
recorded during pulses of 1 s to + 10 mV from V  = − 80 mV from n = 6 TS2-









Taken together, all these findings suggest that hippocampal neurons of TS2-neo
mice express Cav1.2-mutated channels with the expected phenotype of
chromaffin cells and that the TS2-neo mouse is a promising animal model to
investigate the pathophysiology of TS2-induced autism.
Mistuned excitation–transcription coupling at the
basis of TS-induced autism
Cav1.2 channels are critical mediators of the activity-dependent gene expression
that regulate synaptic and homeostatic plasticity [64, 99]. L-type channels
convert the rapid firing of neurons into dynamic signals directed to the nucleus
and play, as such, a key role in the regulation of neuronal E-T coupling [99].
Since the control of E-T coupling is critically important for long-term adaptive
changes during neuronal development, specific Cav1.2 channels mistuning could
drastically affect neuronal development and cause neuropsychiatric disorders
such as schizophrenia, bipolar disorder, and ASD. Concerning the TS-induced
form of autism, there is evidence now that the G406R mutation acts
intracellularly by altering E-T signals through different intracellular pathways.
They require either a Ca -flux independent cascade of events [3, 51, 82, 83] or
a combination of Ca  ion influx and voltage-dependent conformational change
of Cav1.2 channels (V∆C) [52].
The “Ca  flux-independent” mechanism is based on the observation that
G406R-mutated Cav1.2 channels favor the activity-dependent dendrite retraction
induced by long-lasting not physiological depolarizations (1–9 h in 67 mM KCl)
in human iPSCs-derived cortical neurons [51]. Dendrite retraction occurs in the
presence of Ba  and when mutant Cav1.2 channels are blocked by nimodipine
proving that shortening of dendrites is independent of Ca -permeation through
the L-type G406R mutant channel. The mechanism is triggered by the ectopic
activation of the RhoA signaling cascade through the down regulation of the
small RGK protein Gem that occurs due the weak binding of TS mutants to
Gem. Loss of Gem, which is effectively bound to β-subunits in the AID domain
of the I-II linker, increases the percentage of free β-subunits that could drive
signals to the nucleus. It is important, however, that these interesting data are
carefully evaluated in different neuronal preparations (see for instance [65]).
In line with the idea that TS signaling may simply proceed through Ca  flux-
independent conformational changes of mutated Cav1.2 channels are some
recent findings showing that in HEK293 cells transfected with Cav1.2 α1/β2b/
α2δ-subunits, membrane depolarization triggers the activation of c-Fos and
MeCP2 via the Ras/ERK/CREB pathway [83]. The depolarization-induced c-Fos
and MeCP2 activation occurs regardless of Ca  permeation through the
channels but is strictly dependent on the presence of intracellular β2 subunit.
Both mutated G406R and G402S isoforms mediate E-T coupling through the
Ras/ERK/CREB pathway. However, due to the leftward voltage shift of channel
activation, only the autism-associated G406R mutant exhibits a depolarization-
independent CREB phosphorylation and spontaneous transcription of cFos and
MeCP2 [84]. In conclusion, the enhanced G406R mutant activity at rest is
sufficient to account for the increased basal transcriptional activation and
dysregulated gene activity that may lead to autism.
Li et al. [52] have recently proposed an alternative ET coupling based on the
sequential occurrence of two events. Ca  influx first mobilizes actin-bound
CaMKII, freeing and subsequently accumulating the enzyme with calcineurin
through a voltage-dependent conformational change (V∆C)–mediated
mechanism. Neither signal alone (Ca  influx and V∆C) is sufficient to activate
ET coupling nor can signal order be inverted. Using primary cultures of cortical
and hippocampal neurons transfected with fused Cav1.2 to an ATP-gated, Ca -
permeable, tandem-trimeric P2X2 channel (ttP2X-CaV1.2 chimera), the authors












activation of βCaMKII (or α/βCaMKII heteromultimers) is a prerequisite for
their subsequent V∆C-mediated accumulation at Cav1.2 channels and for
downstream signaling to pCREB (possibly by shuttling Ca /CaM to the nucleus
via γCaMKII (see ref. (55)). Interestingly, under conditions of fixed Ca  fluxes,
TS G406R mutant in the Cav1.2 portion of the fused ttP2X chimera exhibited
gain-of-function V∆C signaling. The α/βCaMKII and CREB signaling increased
by ~ 30 to 70%, while the TS G402S mutant had nearly no effect, confirming
that mistuning of V∆C is associated with the G406R but not with the G402S
mutant of TS, in correlation with the observed autistic symptoms in TS2
individuals.
Conclusions and perspectives
Conclusions As discussed in this review, the work of many groups in the last
15 years has allowed collecting an impressive amount of data that lead to some
preliminary conclusion about the molecular and cellular events associated with
the Cav1.2 GOF mutations leading to the autistic form of typical [86, 87] and
atypical TS [42]. A first conclusion is that the slowing of inactivation gating that
causes increased Ca  entry in TS-mutated neurons may contribute, but is
unlikely the parameter that sets the conditions for changing neuronal firing and
developing ASD. Autism is absent in TS2 patients bearing the G402S mutation
on exon 8, despite the mutation induces delayed Cav1.2 channel inactivation. A
second conclusion is that the “leftward shifts” of the activation and SSI gatings
of Cav1.2 mutants are not the only parameters that trigger the autistic forms of
TS. Development of ASD requires GOF mutations with the “left-shifts” but
needs to be located at specific sites, i.e., close to one of the four S6 segments of
Cav1.2 channels, as in the case of the G406R mutation located in IS6. A third
conclusion is that increased Ca  entry associated with Cav1.2 TS-variants is not
the only mechanism required to trigger morphological and functional changes to
TS-mistuned neurons, possibly causing autism [51, 69]. TS-induced
conformational changes, either directly associated with the α1-subunit [52] or to
cytoplasmic β-subunits of Cav1.2 channels [83, 84], are also required to regulate
the excitation–transcription coupling to the nucleus that possibly leads to
developmental neuronal dysfunction. A final conclusion concerns the different
approaches used to study the mechanisms underlying ASD in TS patients.
Among the various, the use of TS2-neo KI mouse (or any newly designed TS
mouse model) and iPSC-derived neurons from TS patients appears undoubtedly
the most promising.
Perspectives iPSC-derived neurons will certainly help to progress in
identifying mistuned neuronal excitability, synaptic plasticity, and specific





excitation–transcription coupling controlling the expression of ASD-related
genes in TS-mutated neurons (see ref. (63) for a recent review). However,
unquestionably, the most promising advancement is expected from a wider use
of the available TS2-neo mouse model. Presently, there is an impressive lack of
information about the mistuned function of single neuron excitability,
synaptogenesis, and AP firing both in reconstituted neuronal microcircuits and in
in vitro brain areas, which demands for a common multidisciplinary effort to
investigate TS-altered neurons to reach viable pathophysiological hypothesis on
how Cav1.2 TS mutants generate autism. Nothing is known on how excitatory
pyramidal neurons and inhibitory GABAergic interneurons change their
spontaneous and current-evoked mode of firing (tonic vs. bursts). It is still
undetermined whether the number of functioning neurons forming spontaneously
active microcircuits increases or decreases in TS-mutated neurons and if the
length and number of dendrites is retracted in an activity-dependent manner
using physiological stimulations, such as trains of AP. Not last, it would be
important to know how the excitatory (E) and inhibitory (I) synapses alter their
strength (RRP, probability of vesicle release, quantal size) and how the E/I
balance of cultured neuronal networks and brain slices changes during
development in TS-mutated neurons.
A final great advantage of using mouse models of monogenic ASD is the
possibility of attempting a pharmacological treatment to ameliorate ASD-like
behavior. In the case of TS, since the symptoms are associated with a Cav1.2
channel GOF, L-type Ca  channel blockers are the most promising and
immediate therapeutic option. At the light of the present findings, however, the
search from new “Ca  channel modulators” able to shift back the voltage-
dependent activation of Cav1.2-mutated channels without blocking the channel
should also be boosted. Drugs causing a “positive shift” of Cav1.2 channel
activation would specifically act on the increased window Ca  current at rest,
without reducing Ca  fluxes during cell activity (tonic or burst firings), as
classical L-type channel blockers do. This will preserve intact activity-dependent
Ca  signalings in developing neurons.
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